Urigen Pharmacueticals' Reverse Merger Round

Urigen Pharmacueticals raised a round of funding on July 16, 2007. Investors include Valentis.

Urigen specializes in the design and commercialization of innovative products for patients with urological ailments. The company develops products for amelioration of Painful Bladder Syndrome (PBS), U…

Articles about Urigen Pharmacueticals' Reverse Merger Round: